Found 604 bookmarks
Newest
Patient-Reported Experiences of Persistent Post–COVID-19 Conditions After Hospital Discharge During the Second and Third Waves of the Pandemic in Switzerland: Cross-Sectional Questionnaire Study
Patient-Reported Experiences of Persistent Post–COVID-19 Conditions After Hospital Discharge During the Second and Third Waves of the Pandemic in Switzerland: Cross-Sectional Questionnaire Study

“Study from Switzerland: 245 COVID-19 patients surveyed 4 months post-hospital discharge.

Only 28.2% were symptom-free.

Women and those with longer hospital stays reported more persistent symptoms.

76.4% had memory and concentration issues.

·publichealth.jmir.org·
Patient-Reported Experiences of Persistent Post–COVID-19 Conditions After Hospital Discharge During the Second and Third Waves of the Pandemic in Switzerland: Cross-Sectional Questionnaire Study
COVID can cause new health problems even 3 years after infection, study finds: 'We don’t know what’s going to happen at 10 years'
COVID can cause new health problems even 3 years after infection, study finds: 'We don’t know what’s going to happen at 10 years'
“People are developing new-onset disease as the result of an infection that they had three years ago,” says Dr. Ziyad Al-Aly, a clinical epidemiologist at Washington University in St. Louis and lead author of the study. ‘It challenges the notion that these viruses are sort of self-contained or that after the acute first phase, they become inconsequential.’”
·fortune.com·
COVID can cause new health problems even 3 years after infection, study finds: 'We don’t know what’s going to happen at 10 years'
The Plan to Stop Every Respiratory Virus at Once
The Plan to Stop Every Respiratory Virus at Once

“The Plan to Stop Every Respiratory Virus at Once The benefits of ventilation reach far beyond the coronavirus. What if we stop taking colds and flus for granted, too?”

·theatlantic.com·
The Plan to Stop Every Respiratory Virus at Once
Military Pilots Reported 1,700% More Medical Incidents During the Pandemic. The Pentagon Says They Just Had COVID | Military.com
Military Pilots Reported 1,700% More Medical Incidents During the Pandemic. The Pentagon Says They Just Had COVID | Military.com
February 2023: “The number of medical events that triggered official reporting requirements among U.S. military pilots rose more than 1,700% from 2019 to 2022, an increase the Pentagon says was the result of COVID.”
·military.com·
Military Pilots Reported 1,700% More Medical Incidents During the Pandemic. The Pentagon Says They Just Had COVID | Military.com
Dr. Amer, Ohio State Univ. on IPM today, "I got COVID three times...after the second time, I suffered from brain fog..it was the most horiftying experience of my life. This was very scary..my job depends on my brain. All of a sudden I couldn't even type...it was really shocking."
Dr. Amer, Ohio State Univ. on IPM today, "I got COVID three times...after the second time, I suffered from brain fog..it was the most horiftying experience of my life. This was very scary..my job depends on my brain. All of a sudden I couldn't even type...it was really shocking."
·x.com·
Dr. Amer, Ohio State Univ. on IPM today, "I got COVID three times...after the second time, I suffered from brain fog..it was the most horiftying experience of my life. This was very scary..my job depends on my brain. All of a sudden I couldn't even type...it was really shocking."
FDA Could Soon Limit Use of Only Drug for COVID Prevention
FDA Could Soon Limit Use of Only Drug for COVID Prevention
Pemivibart (Pemgarda) should only be used for pre-exposure prophylaxis of COVID-19 in immunocompromised patients when the combined national frequency of SARS-CoV-2 variants with substantially reduced susceptibility to the drug is less than or equal to 90%, the FDA announced on Monday.
Pemivibart (Pemgarda) should only be used for pre-exposure prophylaxis of COVID-19 in immunocompromised patients when the combined national frequency of SARS-CoV-2 variants with substantially reduced susceptibility to the drug is less than or equal to 90%, the FDA announced on Monday.
·medpagetoday.com·
FDA Could Soon Limit Use of Only Drug for COVID Prevention
Tam 32 431
Tam 32 431

April 2024: 'Long-Term Effects of COVID-19: The Stories of 2 Physicians Who Became Patients'

'James Mwangi, MD; Jeffrey N. Siegelman, MD - Emory Univ. School of Medicine'

'Our intention in this article is to generate more awareness about long COVID...'

·ncbi.nlm.nih.gov·
Tam 32 431
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry | mSphere
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry | mSphere

Study: How SARS-CoV-2 is adapting to better infect people. This study found that the newer Omicron subvariants can replicate better in human cells compared to earlier Omicron strains.

"SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry"

·journals.asm.org·
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry | mSphere
So we are approaching the field hospital & freezer trucks stage. Good thing covid is over. Couldn't have gotten here without complete failure of societal leadership. Shoutout to everyone just following orders & the people giving zero fucks about walking around sick & maskless.
So we are approaching the field hospital & freezer trucks stage. Good thing covid is over. Couldn't have gotten here without complete failure of societal leadership. Shoutout to everyone just following orders & the people giving zero fucks about walking around sick & maskless.
·x.com·
So we are approaching the field hospital & freezer trucks stage. Good thing covid is over. Couldn't have gotten here without complete failure of societal leadership. Shoutout to everyone just following orders & the people giving zero fucks about walking around sick & maskless.
Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in an Exploratory Analysis from Ongoing CANOPY Phase 3 Clinical Trial | Invivyd
Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in an Exploratory Analysis from Ongoing CANOPY Phase 3 Clinical Trial | Invivyd
PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in Exploratory Analysis Ongoing Phase 3 Clinical Trial May be useful for PRE-EXPOSURE PROPHYLAXIS (Prep) in immunocompromised & immunocompetent
·investors.invivyd.com·
Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in an Exploratory Analysis from Ongoing CANOPY Phase 3 Clinical Trial | Invivyd
“Getting Covid was worth it!” I was disabled by my 2020 Covid infection, mostly bed-bound for two years, then I was reinfected in 2022. My driver’s license expired “during the pandemic,” & NYS made me take a class & a road test. I failed the road test due to my Covid-affected…
“Getting Covid was worth it!” I was disabled by my 2020 Covid infection, mostly bed-bound for two years, then I was reinfected in 2022. My driver’s license expired “during the pandemic,” & NYS made me take a class & a road test. I failed the road test due to my Covid-affected…
·x.com·
“Getting Covid was worth it!” I was disabled by my 2020 Covid infection, mostly bed-bound for two years, then I was reinfected in 2022. My driver’s license expired “during the pandemic,” & NYS made me take a class & a road test. I failed the road test due to my Covid-affected…
BREAKING: U.S. Faces Unprecedented COVID-19 Surge with 1.2 Million New Cases Daily
BREAKING: U.S. Faces Unprecedented COVID-19 Surge with 1.2 Million New Cases Daily

Covid has never been over. As of August 26, 2024, the U.S. is grappling with an alarming surge in COVID-19 infections, with a record-breaking 1.2 million new cases reported each day.

1 in 41 people is currently infected.

This surge marks a dramatic escalation compared to previous years. The current wave is more intense than those experienced in Year 1, Year 2, and Year 4 of the pandemic.

·x.com·
BREAKING: U.S. Faces Unprecedented COVID-19 Surge with 1.2 Million New Cases Daily
Perspective: I Thought I Was Protected but I Still Got Long Covid
Perspective: I Thought I Was Protected but I Still Got Long Covid
“I was aware of Long COVID since I had persistent loss of taste and smell going back to my first infection, but I never really considered it to be Long COVID, as it did not have a major effect on my life. The third infection is really what tipped me into Long COVID. Since then, I've had intermittent chest pain, heart palpitations, various neurological issues (face numbness, buzzing in the feet), joint pain, anxiety, issues with my vision, fatigue, complete alcohol and caffeine intolerance. I alternate between good weeks and bad weeks,”
·johnsnowproject.org·
Perspective: I Thought I Was Protected but I Still Got Long Covid
I tested positive for covid on August 12th.
I tested positive for covid on August 12th.

I tested positive for covid on August 12th.

I'm still symptomatic (cough, recurring fevers). In addition, I have two new rashes, a very bloody UTI, kidney injury, and liver injury.

My POTS and EDS are worse.

This was my first covid. And I'm immunocompromised.

·x.com·
I tested positive for covid on August 12th.